On the important occasion of World AIDS Day on 1 December 2007, the International Federation of Pharmaceutical Manufacturers & Associations has underlined the research-based pharmaceutical industry's commitment to address HIV/AIDS. The industry's increasing R&D efforts in this area include new therapeutic approaches to provide additional treatments when resistance to established antiretroviral medicines emerges, as well as development of an increasing number of pediatric formulations...industry programs such as the Accelerating Access Initiative are helping to increase antiretroviral coverage in the developing world…